Goodwin, Latham Lead Biotech Kardigan's $400M IPO
Venture-backed Kardigan Inc., a biotechnology firm developing therapies for cardiovascular diseases, hit the public markets on Thursday after raising $400 million in its initial public offering....To view the full article, register now.
Already a subscriber? Click here to view full article